NOVAVAX INC Expense Breakdown
No Expense Breakdown for NVAX on this site yet.
- 2026-06-30: Reportable $14.25M.
- 2025-06-30: Reportable $15.32M.
Source checked: the stored Expense Breakdown page for NVAX.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $14.25M |
|---|
| 2025-06-30 | $15.32M |
|---|
Research And Development Expense Employee And Benefit Expenses: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $30.82M |
|---|
| 2025-06-30 | $36.15M |
|---|
Research And Development Expense Facility And Other Research And Development Expenses: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $15.97M |
|---|
| 2025-06-30 | $22.05M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $26.66M |
|---|
| 2025-06-30 | $43.61M |
|---|